GBS VENTURES
Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnology product development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics. GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.
GBS VENTURES
Social Links:
Industry:
Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
+61 0429 652 184
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Analytics Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS PHP COVID-19 Apache 2.4 Google Analytics Classic
Similar Organizations
3x5 Partners
3x5 Partners is a growth-oriented venture capital firm.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-16 | Moximed | GBS Ventures investment in Series C - Moximed | 40 M USD |
| 2017-03-16 | Moximed | GBS Ventures investment in Series C - Moximed | 50 M USD |
| 2016-01-27 | Moximed | GBS Ventures investment in Series B - Moximed | 12.62 M USD |
| 2016-01-07 | Elastagen | GBS Ventures investment in Series B - Elastagen | 13 M AUD |
| 2015-05-07 | Moximed | GBS Ventures investment in Series B - Moximed | 33 M USD |
| 2014-09-23 | Ivantis | GBS Ventures investment in Series B - Ivantis | 25 M USD |
| 2014-09-03 | AirXpanders | GBS Ventures investment in Series E - AirXpanders | 1000 K USD |
| 2014-04-10 | Spinifex Pharmaceuticals | GBS Ventures investment in Series C - Spinifex Pharmaceuticals | 45 M USD |
| 2014-04-03 | Neurovance | GBS Ventures investment in Series A - Neurovance | 6.3 M USD |
| 2014-01-13 | Ivantis | GBS Ventures investment in Series B - Ivantis | 14 M USD |